Documents patient death during Pfizer hemophilia drug trial and raises questions about pharmaceutical safety oversight protocols. Examines clinical trial design standards and regulatory accountability in drug development processes.
Patient Dies During Pfizer Hemophilia Drug Trial
Documents patient death during Pfizer hemophilia drug trial and raises questions about pharmaceutical safety oversight protocols. Examines clinical trial design standards and regulatory accountability in drug development processes. Read the…